1.
Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, Labie D: Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA 1984;81:1771–1773.
2.
Nagel RL, Fleming AF: Genetic epidemiology of the beta s gene. Baillieres Clin Haematol 1992;5:331–365.
3.
Powars DR, Chan L, Schroeder WA: Beta S-gene-cluster haplotypes in sickle cell anemia: clinical implications. Am J Pediatr Hematol Oncol 1990;12:367–374.
4.
Padmos MA, Roberts GT, Sackey K, Kulozik A, Bail S, Morris JS, Serjeant BE, Serjeant GR: Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br J Haematol 1991;79:93–98.
5.
El-Hazmi MA: Beta-globin gene haplotypes in the Saudi sickle cell anaemia patients. Hum Hered 1990;40:177–186.
6.
Adekile AD: Historical and anthropological correlates of beta s haplotypes and alpha- and beta-thalassemia alleles in the Arabian Peninsula. Hemoglobin 1997;21:281–296.
7.
Al-Saqladi A, Delpisheh A, Bin-Gadeem H, Brabin BJ: Severity of sickle cell disease in Yemeni children. J Trop Pediatr 2009;55:208–209.
8.
Montgomery J, Wittwer CT, Palais R, Zhou L: Simultaneous mutation scanning and genotyping by high-resolution DNA melting analysis. Nature Protoc 2007;2:59–66.
9.
Vivenes De Lugo M, Rodriguez-Larralde A, Castro De Guerra D: Beta-globin gene cluster haplotypes as evidence of African gene flow to the northeastern coast of Venezuela. Am J Hum Biol 2003;15:29–37.
10.
Zago MA, Silva WA Jr, Dalle B, Gualandro S, Hutz MH, Lapoumeroulie C, Tavella MH, Araujo AG, Krieger JE, Elion J, Krishnamoorthy R: Atypical beta(s) haplotypes are generated by diverse genetic mechanisms. Am J Hematol 2000;63:79–84.
11.
Steinberg MH, Lu ZH, Nagel RL, Venkataramani S, Milner PF, Huey L, Safaya S, Rieder RF: Hematological effects of atypical and cameroon beta-globin gene haplotypes in adult sickle cell anemia. Am J Hematol 1998;59:121–126.
12.
El-Hazmi MA, Warsy AS: Xmn I polymorphic site in Yemeni sickle cell disease patients. J Trop Pediatr 2000;46:25–29.
13.
Inati A, Taher A, Bou Alawi W, Koussa S, Kaspar H, Shbaklo H, Zalloua PA: Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol 2003;70:79–83.
14.
El-Hazmi MA, Warsy AS: Alpha thalassaemia in Yemeni children with sickle cell disease. J Trop Pediatr 1999;45:370–374.
15.
Liu L, Muralidhar S, Singh M, Sylvan C, Kalra IS, Quinn CT, Onyekwere OC, Pace BS: High-density SNP genotyping to define beta-globin locus haplotypes. Blood Cells Mol Dis 2009;42:16–24.
16.
El-Hazmi MA, Warsy AS, Bashir N, Beshlawi A, Hussain IR, Temtamy S, Qubaili F: Haplotypes of the beta-globin gene as prognostic factors in sickle-cell disease. East Mediterr Health J 1999;5:1154–1158.
17.
Samarah F, Ayesh S, Athanasiou M, Christakis J, Vavatsi N: Beta(s)-globin gene cluster haplotypes in the west bank of Palestine. Hemoglobin 2009;33:143–149.
18.
Aluoch JR, Kilinc Y, Aksoy M, Yuregir GT, Bakioglu I, Kutlar A, Kutlar F, Huisman TH: Sickle cell anaemia among Eti-Turks: haematological, clinical and genetic observations. Br J Haematol 1986;64:45–55.
19.
Abbes S, Fattoum S, Vidaud M, Goossens M, Rosa J: Sickle cell anemia in the Tunisian population: haplotyping and Hb F expression. Hemoglobin 1991;15:1–9.
20.
Boussiou M, Loukopoulos D, Christakis J, Fessas P: The origin of the sickle mutation in Greece: evidence from beta s globin gene cluster polymorphisms. Hemoglobin 1991;15:459–467.
21.
Schiliro G, Samperi P, Consalvo C, Gangarossa S, Testa R, Miraglia V, Lo Nigro L: Clinical, hematological, and molecular features in Sicilians with sickle cell disease. Hemoglobin 1992;16:469–480.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.